Viewing nowNupito Tablets 20 mg (Atorvastatin Calcium Hydrate)
Atorvastatin Calcium Hydrate 21.7mg
Tablet · Prescription medication
Litepharm Tech Co., Ltd.

MFDS item code 201902555 · Approved 2019.04.24 · Insurance code 690300880
Improvement of hyperlipidemia, improvement of familial hypercholesterolemia in children, and prevention of cardiovascular disease
This medication helps reduce the risk of cardiovascular diseases. It particularly lowers the risk of myocardial infarction and stroke in adults with multiple risk factors such as hypertension, smoking, and hyperlipidemia, as well as in patients with type 2 diabetes. Additionally, it contributes to improving cardiovascular health by reducing the risk of complications following angioplasty and chronic stable angina. In patients with existing coronary heart disease, it alleviates the burden on the heart by reducing the risk of hospitalization due to myocardial infarction, stroke, or congestive heart failure. Furthermore, in patients with hyperlipidemia, it effectively regulates cholesterol and triglyceride levels while increasing HDL cholesterol to enhance vascular health. For pediatric patients with a family history or risk factors, it is used as an adjunct therapy to lower total cholesterol and LDL cholesterol levels. As a result, it is very beneficial for the prevention and treatment of cardiovascular diseases.
Patients should follow a standard cholesterol-lowering diet before and during treatment with atorvastatin. This medicine may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is atorvastatin 10 mg once daily. However, patients requiring a greater reduction in LDL cholesterol may start with 20 mg or 40 mg once daily (only for patients requiring an LDL cholesterol reduction of 45% or more). This medicine is administered at a dose ranging from 10 ~ 80 mg once daily. The initial and maintenance doses of this medicine should be individualized according to patient characteristics, taking into account the treatment goal and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or adjusting the dose, and the dose should be adjusted accordingly. Because the goal of treatment is to reduce LDL cholesterol, it is recommended that LDL cholesterol levels be used when initiating treatment and evaluating the response. However, if LDL cholesterol levels are unavailable, total cholesterol levels may be used to monitor the treatment response. Patients with homozygous familial hypercholesterolemia The dose of this medicine is 10 ~ 80 mg once daily. Administer it in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are not available. ○ Patients with renal impairment: Renal disease does not affect the plasma concentration or LDL cholesterol-lowering effect of atorvastatin; therefore, no dose adjustment is necessary. ○ Elderly patients: The efficacy and safety in elderly patients aged 70 years or older are generally similar to those in adult patients.
Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended initial dose is 10 mg of this medicine daily, and the recommended maximum dose is 20 mg daily (there are no clinical data on administration of doses of this medicine higher than 20 mg in pediatric patients).
This medication may cause adverse muscle symptoms, so if you experience severe muscle pain or weakness or if your creatine kinase levels rise significantly, you should stop taking it immediately and consult your doctor. If you have serious infections, hypotension, major surgery, trauma, metabolic or electrolyte abnormalities, or uncontrolled epilepsy, it may be necessary to temporarily discontinue this medication. This medication should not be used in patients with poor liver function, liver disease, pregnant women or women who might become pregnant, children under 10 years of age, and patients taking certain medications. Patients with a history of alcohol abuse or liver disease, those with reduced kidney function, patients with hypothyroidism, those with a history of muscle disorders, and the elderly should use this medication with caution, and it is important to periodically check muscle and liver function through blood tests before and during treatment. During treatment with this medication, if you experience symptoms such as abnormal liver function, muscle pain, weakness, fever, or fatigue, you must inform your healthcare provider immediately, as discontinuation of the medication may be necessary. Additionally, this medication can interact with various drugs, so if you are taking other medications, be sure to inform your doctor or pharmacist, especially with certain antibiotics, antifungals, antivirals, immunosuppressants, and grapefruit juice. Women of childbearing age must use appropriate contraceptive methods while taking this medication, and if pregnancy is confirmed, they should discontinue use immediately. Nursing mothers should not take this medication, and caution is especially required for children and the elderly when using this medication. In cases of overdose, there is no specific antidote, so you should visit a hospital immediately for symptomatic treatment and blood tests. Finally, this medication should be stored out of reach of children and kept in its original container to prevent misuse or quality degradation.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture, so it should be stored in a tightly sealed container. It is best to maintain a storage temperature between 1 and 30 degrees Celsius.
White round film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowAtorvastatin Calcium Hydrate 21.7mg
Tablet · Prescription medication
Litepharm Tech Co., Ltd.

Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.